BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2665032)

  • 21. Acute cardiomyopathy induced by the vasodilating antihypertensive agent minoxidil.
    Herman EH; Balazs T; Young R; Earl FL; Krop S; Ferrans VJ
    Toxicol Appl Pharmacol; 1979 Mar; 47(3):493-503. PubMed ID: 442091
    [No Abstract]   [Full Text] [Related]  

  • 22. Large pericardial effusion induced by minoxidil.
    Çilingiroğlu M; Akkuş N; Sethi S; Modi KA
    Turk Kardiyol Dern Ars; 2012 Apr; 40(3):255-8. PubMed ID: 22864322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of minoxidil.
    Miller DD; Love DW
    Am J Hosp Pharm; 1980 Jun; 37(6):808-14. PubMed ID: 6994495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal toxic epidermal necrolysis associated with minoxidil.
    Karaoui LR; Chahine-Chakhtoura C
    Pharmacotherapy; 2009 Apr; 29(4):460-7. PubMed ID: 19323621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertrichosis due to minoxidil.
    Burton JL; Marshall A
    Br J Dermatol; 1979 Nov; 101(5):593-5. PubMed ID: 518830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of refractory hypertensive patients with minoxidil.
    Mitchell HC; Pettinger WA
    JAMA; 1978 May; 239(20):2131-8. PubMed ID: 642154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic properties of minoxidil: a new hypotensive agent.
    DuCharme DW; Freyburger WA; Graham BE; Carlson RG
    J Pharmacol Exp Ther; 1973 Mar; 184(3):662-70. PubMed ID: 4631469
    [No Abstract]   [Full Text] [Related]  

  • 28. Toxicity of minoxidil - Comprehensive in silico prediction of main toxicity endpoints: Acute toxicity, irritation of skin and eye, genetic toxicity, health effect, cardiotoxicity and endocrine system disruption.
    Frydrych A; Jurowski K
    Chem Biol Interact; 2024 Apr; 393():110951. PubMed ID: 38484827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pericardial effusion associated with minoxidil therapy: case reports.
    Kadir S; Osinfade K; Lawal SO
    West Afr J Med; 1992; 11(1):79-81. PubMed ID: 1637746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central chorioretinopathy associated with topical use of minoxidil 2% for treatment of baldness.
    Scarinci F; Mezzana P; Pasquini P; Colletti M; Cacciamani A
    Cutan Ocul Toxicol; 2012 Jun; 31(2):157-9. PubMed ID: 21939432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual case of right atrial reinfarction.
    Radojevic N; Savic S; Aleksic V; Cukic D
    J Forensic Leg Med; 2012 Feb; 19(2):105-8. PubMed ID: 22281221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
    Winquist RJ; Heaney LA; Wallace AA; Baskin EP; Stein RB; Garcia ML; Kaczorowski GJ
    J Pharmacol Exp Ther; 1989 Jan; 248(1):149-56. PubMed ID: 2464055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A model of orthostatic hypotension in the conscious monkey using lower body negative pressure.
    Murphy DJ; Renninger JP; Ju H
    J Pharmacol Toxicol Methods; 2006; 54(2):106-15. PubMed ID: 16650782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the hyperfiltration of minoxidil result in increased proteinuria and loss of renoprotection conferred by angiotensin inhibition?
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    Kidney Blood Press Res; 2006; 29(1):54-9. PubMed ID: 16645303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minoxidil for control of acute blood pressure elevation in chronically hypertensive children.
    Strife CF; Quinlan M; Waldo FB; Fryer CJ; Jackson EC; Welch TR; McEnery PT; West CD
    Pediatrics; 1986 Nov; 78(5):861-5. PubMed ID: 3763300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of refractory hypertension with combined minoxidil and captopril in low doses].
    Palatini P; Pessina AC; Sperti G; Fortunato V; Gava R; Dal Palù C
    G Ital Cardiol; 1984 Jun; 14(6):401-6. PubMed ID: 6148288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole body and regional hemodynamic effects of minoxidil in the conscious dog.
    Humphrey SJ; Zins GR
    J Cardiovasc Pharmacol; 1984; 6(6):979-88. PubMed ID: 6084789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamics of dexamethasone-induced hypertension in the rat.
    Ong SL; Zhang Y; Sutton M; Whitworth JA
    Hypertens Res; 2009 Oct; 32(10):889-94. PubMed ID: 19644504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute electrocardiographic effects of minoxidil in hypertensive subjects].
    Sánchez Torres G; Panzzi ME; Kuri J; Trevethan S; Castillo LR
    Arch Inst Cardiol Mex; 1983; 53(1):49-56. PubMed ID: 6870384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of protein sulfation in vasodilation induced by minoxidil sulfate, a K+ channel opener.
    Meisheri KD; Oleynek JJ; Puddington L
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1091-7. PubMed ID: 1890613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.